Wolfgang Maier

ORCID: 0000-0003-1016-8539
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Dementia and Cognitive Impairment Research
  • Schizophrenia research and treatment
  • Genetic Associations and Epidemiology
  • Alzheimer's disease research and treatments
  • Bipolar Disorder and Treatment
  • Treatment of Major Depression
  • Mental Health Research Topics
  • Tryptophan and brain disorders
  • Health disparities and outcomes
  • Psychiatric care and mental health services
  • Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
  • Genetics and Neurodevelopmental Disorders
  • Neurotransmitter Receptor Influence on Behavior
  • Child and Adolescent Psychosocial and Emotional Development
  • Functional Brain Connectivity Studies
  • Neuroendocrine regulation and behavior
  • Health and Medical Studies
  • Mental Health and Psychiatry
  • Mental Health Treatment and Access
  • Aging and Gerontology Research
  • Stress Responses and Cortisol
  • Genomic variations and chromosomal abnormalities
  • Psychosomatic Disorders and Their Treatments
  • Frailty in Older Adults
  • Receptor Mechanisms and Signaling

University of Bonn
2016-2025

University Hospital Bonn
2016-2025

German Center for Neurodegenerative Diseases
2014-2024

Klinik und Poliklinik für Psychiatrie und Psychotherapie
2009-2020

SUNY Upstate Medical University
2018

Southwest Jiaotong University
2018

Shanghai Jiao Tong University
2018

Life & Brain (Germany)
2018

Wuxi People's Hospital
2018

Nanjing Medical University
2018

Oxytocin (OT) is becoming increasingly established as a prosocial neuropeptide in humans with therapeutic potential treatment of social, cognitive, and mood disorders. However, the OT general facilitator human learning empathy unclear. The current double-blind experiments on healthy adult male volunteers investigated first whether intranasal enhanced performance feedback-guided item–category association task where either social (smiling angry faces) or nonsocial (green red lights)...

10.1523/jneurosci.5538-09.2010 article EN cc-by-nc-sa Journal of Neuroscience 2010-04-06
Raymond K. Walters Renato Polimanti Emma C. Johnson Jeanette N. McClintick Mark J. Adams and 95 more Amy Adkins Fazil Alıev Silviu‐Alin Bacanu Anthony Batzler Sarah Bertelsen Joanna M. Biernacka Tim B. Bigdeli Li‐Shiun Chen Toni‐Kim Clarke Yi‐Ling Chou Franziska Degenhardt Anna R. Docherty Alexis C. Edwards Pierre Fontanillas Jerome C. Foo Louis Fox Josef Frank Ina Giegling Scott D. Gordon Laura M. Hack Annette M. Hartmann Sarah M. Hartz Stefanie Heilmann‐Heimbach Stefan Herms Colin A. Hodgkinson Per Hoffmann Jouke‐Jan Hottenga Martin A. Kennedy Mervi Alanne-Kinnunen Bettina Konte Jari Lahti Marius Lahti‐Pulkkinen Dongbing Lai Lannie Ligthart Anu Loukola Brion S. Maher Hamdi Mbarek Andrew M. McIntosh Matthew B. McQueen Jacquelyn L. Meyers Yuri Milaneschi Teemu Palviainen John F. Pearson Roseann E. Peterson Samuli Ripatti Euijung Ryu Nancy L. Saccone Jessica E. Salvatore Sandra Sanchez‐Roige Melanie L. Schwandt Richard Sherva Fabian Streit Jana Strohmaier Nathaniel Thomas Jen‐Chyong Wang Bradley T. Webb Robbee Wedow Leah Wetherill Amanda G. Wills Jason D. Boardman Danfeng Chen Doo‐Sup Choi William Copeland Robert Culverhouse Norbert Dahmen Louisa Degenhardt Benjamin W. Domingue Sarah L. Elson Mark A. Frye Wolfgang Gäbel Caroline Hayward Marcus Ising Margaret A. Keyes Falk Kiefer John R. Kramer Samuel Kuperman Susanne Lucae Michael T. Lynskey Wolfgang Maier Karl Mann Satu Männistö Bertram Müller‐Myhsok Alison D. Murray John I. Nürnberger Aarno Palotie Ulrich W. Preuss Katri Räikkönen Maureen Reynolds Monika Ridinger Norbert Scherbaum Marc A. Schuckit Michael Soyka Jens Treutlein Stephanie H. Witt Norbert Wodarz

10.1038/s41593-018-0275-1 article EN Nature Neuroscience 2018-11-19

Context: Subjective memory impairment (SMI) is receiving increasing attention as a pre-mild cognitive (MCI) condition in the course of clinical manifestation Alzheimer disease (AD).Objectives: To determine risk for conversion to any dementia, dementia AD, or vascular by SMI, graded level SMI-related worry and temporal association SMI subsequent MCI.Design: Longitudinal cohort study with follow-up examinations at 1 ⁄2 3 years after baseline.Setting: Primary care medical record registry...

10.1001/archgenpsychiatry.2010.30 article EN Archives of General Psychiatry 2010-04-01

Background Late Onset Alzheimer's disease (LOAD) is the leading cause of dementia. Recent large genome-wide association studies (GWAS) identified first strongly supported LOAD susceptibility genes since discovery involvement APOE in early 1990s. We have now exploited these GWAS datasets to uncover key pathophysiological processes. Methodology applied a recently developed tool for mining data biologically meaningful information dataset. The principal findings were then tested an independent...

10.1371/journal.pone.0013950 article EN cc-by PLoS ONE 2010-11-15

<h3>Importance</h3> Medications that influence the risk of dementia in elderly can be relevant for prevention. Proton pump inhibitors (PPIs) are widely used treatment gastrointestinal diseases but have also been shown to potentially involved cognitive decline. <h3>Objective</h3> To examine association between use PPIs and incident elderly. <h3>Design, Setting, Participants</h3> We conducted a prospective cohort study using observational data from 2004 2011, derived largest German statutory...

10.1001/jamaneurol.2015.4791 article EN JAMA Neurology 2016-02-16

To compare the risk of developing Alzheimer's disease (AD) dementia in late mild cognitive impairment (LMCI), early MCI (EMCI), and subjective memory (SMI) with normal test performance.The baseline sample (n = 2892) prospective cohort study nondemented individuals (German Study on Aging, Cognition Dementia Primary Care Patients) was divided into LMCI, EMCI, SMI, control subjects by delayed recall performance. These groups were subdivided presence self-reported concerns associated experienced...

10.1016/j.jalz.2012.09.017 article EN Alzheimer s & Dementia 2013-01-30

Three sets of research criteria are available for diagnosis Alzheimer's disease in subjects with mild cognitive impairment: the International Working Group-1, Group-2, and National Institute Aging-Alzheimer Association criteria. We compared prevalence prognosis at impairment stage according to these Subjects (n = 1607), 766 whom had both amyloid neuronal injury markers, were recruited from 13 cohorts. used test performance biomarkers classify as prodromal Group-1 Group-2 high likelihood...

10.1093/brain/awv029 article EN Brain 2015-02-17

Significance Sexual monogamy is potentially costly for males, and few mammalian species along with humans exhibit it. The hypothalamic peptide oxytocin (OXT) has been implicated in mediating pair bonds various species, but as yet, we know little about neurobiological factors that might act to promote fidelity, especially men. Here provide evidence a mechanism by which OXT may contribute romantic men enhancing their partner's attractiveness reward value compared other women.

10.1073/pnas.1314190110 article EN Proceedings of the National Academy of Sciences 2013-11-25
Gyungah Jun Carla A. Ibrahim‐Verbaas Maria Vronskaya Jean‐Charles Lambert Jaeyoon Chung and 95 more Adam C. Naj Brian W. Kunkle Li‐Shun Wang Joshua C. Bis Céline Bellenguez Denise Harold Kathryn L. Lunetta Anita L. DeStefano Benjamin Grenier‐Boley Rebecca Sims Gary W. Beecham Albert V. Smith Vincent Chouraki Kara L. Hamilton‐Nelson M. Arfan Ikram Nathalie Fiévet Nicola Denning Eden R. Martin Helena Schmidt Yoichiro Kamatani Melanie Dunstan Otto Valladares Agustín Ruiz Laza Diana Zélénika Alfredo Ramı́rez Tatiana Foroud Sung‐Hyuk Choi Anne Boland Tim Becker Walter A. Kukull Sven J. van der Lee Florence Pasquier Carlos Cruchaga Duane Beekly Annette L. Fitzpatrick Olivier Hanon Michael Gill Robert C. Barber Vilmundur Guðnason Dominique Campion Seth Love David A. Bennett Najaf Amin Claudine Berr Magda Tsolaki Joseph D. Buxbaum Oscar L. López Vincent Deramecourt Nick C. Fox Laura B. Cantwell Lluís Tárraga Carole Dufouil John Hardy Paul K. Crane Gudny Eiriksdottir Didier Hannequin Robert Clarke Denis A. Evans Thomas H. Mosley Luc Letenneur Carol Brayne Wolfgang Maier Philip L. De Jager Valur Emilsson Dartigues Jf Harald Hampel M. Ilyas Kamboh Renée F.A.G. de Bruijn Christophe Tzourio Pau Pástor Eric B. Larson Jerome I. Rotter Michael O’Donovan Thomas J. Montine Michael A. Nalls Simon Mead Eric M. Reiman Pálmi V. Jónsson Clive Holmes Peter St George‐Hyslop Merçé Boada Peter Passmore Jens R. Wendland R. Schmidt Kevin Morgan Ashley R. Winslow John Powell M Carasquillo Steven G. Younkin Jóhanna Jakobsdóttir John Kauwe Kirk C. Wilhelmsen Dan Rujescu Markus M. Nöthen Albert Hofman

10.1038/mp.2015.23 article EN Molecular Psychiatry 2015-03-17

To identify biological evidence for Alzheimer disease (AD) in individuals with subjective memory impairment (SMI) and unimpaired cognitive performance to investigate the longitudinal course these subjects.[¹⁸F]fluoro-2-deoxyglucose PET (FDG-PET) structural MRI were acquired 31 subjects SMI 56 controls. Cognitive follow-up testing was performed (average time: 35 months). Differences baseline brain imaging data decline assessed between both groups. Associations of tested.The group showed...

10.1212/wnl.0b013e31826c1a8d article EN Neurology 2012-08-23

This paper provides up-to-date data on service use for mental health problems and disorders among adults aged 18-79 years in Germany derived from the Mental Health Module of German Interview Examination Survey Adults (DEGS1-MH; N=4483). Data are based exclusively self-report. Respondents were examined by clinically trained interviewers with a modified version Composite International Diagnostic DIA-X/M-CIDI to assess diagnoses according criteria DSM-IV-TR. Service use, i.e. contact care...

10.1002/mpr.1438 article EN International Journal of Methods in Psychiatric Research 2014-03-31

The neuropeptide oxytocin (OXT) can enhance the impact of positive social cues but may reduce that negative ones by inhibiting amygdala activation, although it is unclear whether latter causes blunted emotional and mnemonic responses. In two independent double-blind placebo-controlled experiments, each involving over 70 healthy male subjects, we investigated OXT affects modulation startle reactivity aversive stimuli as well subsequent memory for them. Intranasal potentiated acoustic...

10.1073/pnas.1208852109 article EN Proceedings of the National Academy of Sciences 2012-10-16

Background It has been suggested that clinician-rated scales and self-report questionnaires may be interchangeable in the measurement of depression severity, but it not tested whether clinically significant information is lost when assessment restricted to either or instruments. The aim this study test provides relevant short-term treatment outcomes captured by clinician-rating vice versa. Methods In genome-based drugs for (GENDEP), 811 patients with major depressive disorder treated...

10.1002/da.21993 article EN Depression and Anxiety 2012-08-29
Coming Soon ...